Literature DB >> 16496102

[Vascular emergencies in dermatology].

B Kahle1.   

Abstract

Life-threatening vascular complications of the skin are rare and usually reflect underlying systemic diseases. Lesions are sudden in onset, become necrotic and may be severe or life-threatening. Effective management requires an understanding of the underlying medical condition, such as arterial thrombosis, temporal arteritis, calciphylaxis and purpura fulminans. In contrast, the acute painful symptoms of erythromelalgia often lead to an urgent dermatologic consultation but pose no acute risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16496102     DOI: 10.1007/s00105-005-1089-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  20 in total

Review 1.  Update in rheumatology.

Authors:  David B Hellmann
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

2.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

3.  Lidocaine patch for pain of erythromelalgia: follow-up of 34 patients.

Authors:  Mark D P Davis; Paola Sandroni
Journal:  Arch Dermatol       Date:  2005-10

Review 4.  Does this patient have temporal arteritis?

Authors:  Gerald W Smetana; Robert H Shmerling
Journal:  JAMA       Date:  2002-01-02       Impact factor: 56.272

Review 5.  Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies.

Authors:  R A Marlar; A Neumann
Journal:  Semin Thromb Hemost       Date:  1990-10       Impact factor: 4.180

6.  Temporal arteritis: a cough, toothache, and tongue infarction.

Authors:  David B Hellmann
Journal:  JAMA       Date:  2002-06-12       Impact factor: 56.272

Review 7.  Acute infectious purpura fulminans: pathogenesis and medical management.

Authors:  G L Darmstadt
Journal:  Pediatr Dermatol       Date:  1998 May-Jun       Impact factor: 1.588

8.  A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

Authors:  Gary S Hoffman; Maria C Cid; David B Hellmann; Loic Guillevin; John H Stone; John Schousboe; Pascal Cohen; Leonard H Calabrese; Howard Dickler; Peter A Merkel; Paul Fortin; John A Flynn; Geri A Locker; Kirk A Easley; Eric Schned; Gene G Hunder; Michael C Sneller; Carol Tuggle; Howard Swanson; J Hernández-Rodríguez; Alfons Lopez-Soto; Debora Bork; Diane B Hoffman; Kenneth Kalunian; David Klashman; William S Wilke; Raymond J Scheetz; Brian F Mandell; Barri J Fessler; Gregory Kosmorsky; Richard Prayson; Raashid A Luqmani; George Nuki; Euan McRorie; Yvonne Sherrer; Shawn Baca; Bridgit Walsh; Diane Ferland; Martin Soubrier; Hyon K Choi; Wolfgang Gross; Allen M Segal; Charles Ludivico; Xavier Puechal
Journal:  Arthritis Rheum       Date:  2002-05

9.  [Purpura fulminans. A fatal consequence of a widely used medication?].

Authors:  U R Hengge; C Jochum; E Tschakarjan; J Maschke; R Erbel; K W Schmid; F Otterbach
Journal:  Hautarzt       Date:  2002-07       Impact factor: 0.751

Review 10.  Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy.

Authors:  J Hafner; G Keusch; C Wahl; B Sauter; A Hürlimann; F von Weizsäcker; M Krayenbühl; K Biedermann; U Brunner; U Helfenstein
Journal:  J Am Acad Dermatol       Date:  1995-12       Impact factor: 11.527

View more
  2 in total

1.  Erythromelalgia accompanying rosuvastatin-associated myopathy.

Authors:  Nevio Cimolai; Tomas Cimolai
Journal:  J Dermatol Case Rep       Date:  2009-04-05

Review 2.  [Dermatological conditions requiring intensive care].

Authors:  C Marks; R Marks
Journal:  Hautarzt       Date:  2012-09       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.